{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:22Z","timestamp":1740106942214,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"IMI","award":["Nr 115001"],"award-info":[{"award-number":["Nr 115001"]}]},{"DOI":"10.13039\/501100003494","name":"Herzfelder'sche Familienstiftung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003494","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00204-017-2080-0","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T07:57:20Z","timestamp":1513843040000},"page":"953-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver"],"prefix":"10.1007","volume":"92","author":[{"given":"Marzieh","family":"Nejabat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Riegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabea","family":"Reitinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Subosits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"R\u00f6mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Eichner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bilban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Zell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang W.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Schulte-Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-6531","authenticated-orcid":false,"given":"Bettina","family":"Grasl-Kraupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"2080_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-59745-179-6_33","volume-title":"Androgen excess disorders in women","author":"R Azziz","year":"2007","unstructured":"Azziz R (2007) Clinical and hormonal evaluation of androgen excess. In: Azziz R (ed) Androgen excess disorders in women, Springer, New York, pp 365\u2013375"},{"key":"2080_CR2","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.purol.2013.08.325","volume":"23","author":"C Bastide","year":"2013","unstructured":"Bastide C, Bruy\u00e8re F, Karsenty G, Guy L, Rozet F (2013) Hormonal treatment in prostate cancer. Prog Urol 23:1246\u20131257. doi:10.1016\/j.purol.2013.08.325","journal-title":"Prog Urol"},{"key":"2080_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell MJ, Hines WC (2011) Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17:320\u2013329. doi:10.1038\/nm.2328","journal-title":"Nat Med"},{"key":"2080_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2013.04.025","volume":"59","author":"T B\u00f6hm","year":"2013","unstructured":"B\u00f6hm T, Berger H, Nejabat M, Riegler T, Kellner F, Kuttke M, Sagmeister S, Bazanella M, Stolze K, Daryabeigi A, Bintner N, Murkovic M, Wagner KH, Schulte-Hermann R, Rohr-Udilova N, Huber W, Grasl-Kraupp B (2013) Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis. J Hepatol 59:563\u2013570. doi:10.1016\/j.jhep.2013.04.025","journal-title":"J Hepatol"},{"key":"2080_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbcan.2016.07.004","volume":"1866","author":"MA Cahill","year":"2016","unstructured":"Cahill MA, Jazayeri JA, Catalano SM, Toyokuni S, Kovacevic Z, Richardson DR (2016) The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology. Biochim Biophys Acta 1866:339\u2013349. doi:10.1016\/j.bbcan.2016.07.004","journal-title":"Biochim Biophys Acta"},{"key":"2080_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12672-012-0106-x","volume":"3","author":"GE Dressing","year":"2012","unstructured":"Dressing GE, Alyea R, Pang Y, Thomas P (2012) Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm Cancer 3:101\u2013112. doi:10.1007\/s12672-012-0106-x","journal-title":"Horm Cancer"},{"key":"2080_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/10408444.2013.835786","volume":"44","author":"CR Elcombe","year":"2014","unstructured":"Elcombe CR, Peffer RC, Wolf DC, Bailey J, Bars R, Bell D, Cattley RC, Ferguson SS, Geter D, Goetz A, Goodman JI, Hester S, Jacobs A, Omiecinski CJ, Schoeny R, Xie W, Lake BG (2014) Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol 44:64\u201382. doi:10.3109\/10408444.2013.835786","journal-title":"Crit Rev Toxicol"},{"key":"2080_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrfmmm.2007.06.010","volume":"637","author":"H Ellinger-Ziegelbauer","year":"2008","unstructured":"Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ (2008) Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat Res 637:23\u201339. doi:10.1016\/j.mrfmmm.2007.06.010","journal-title":"Mutat Res"},{"key":"2080_CR9","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. doi:10.1186\/gb-2004-5-10-r80","journal-title":"Genome Biol"},{"key":"2080_CR10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/hep.510250420","volume":"25","author":"B Grasl-Kraupp","year":"1997","unstructured":"Grasl-Kraupp B, Ruttkay-Nedecky B, M\u00fcllauer L, Taper H, Huber W, Bursch W, Schulte-Hermann R (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25:906\u2013912. doi:10.1002\/hep.510250420","journal-title":"Hepatology"},{"key":"2080_CR11","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/carcin\/21.7.1411","volume":"21","author":"B Grasl-Kraupp","year":"2000","unstructured":"Grasl-Kraupp B, Luebeck G, Wagner A, L\u00f6w-Baselli A, de Gunst M, Waldh\u00f6r T, Moolgavkar S, Schulte-Hermann R (2000) Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis 21:1411\u20131421","journal-title":"Carcinogenesis"},{"key":"2080_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1124\/mol.63.5.1012","volume":"63","author":"C Honer","year":"2003","unstructured":"Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, Cornell W, Steele R, Schweitzer R, Schumacher C (2003) Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 63:1012\u20131020","journal-title":"Mol Pharmacol"},{"key":"2080_CR13","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/nar\/gng015","volume":"31","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15","journal-title":"Nucleic Acids Res"},{"key":"2080_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.14573\/altex.1601201","volume":"33","author":"MN Jacobs","year":"2016","unstructured":"Jacobs MN, Colacci A, Louekari K, Luijten M, Hakkert BC, Paparella M, Vasseur P (2016) International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. Altex 33:359\u2013392. doi:10.14573\/altex.1601201","journal-title":"Altex"},{"key":"2080_CR15","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1038\/ncomms11030","volume":"7","author":"Y Kabe","year":"2016","unstructured":"Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, Sugase K, Shimamura T, Ohmura M, Muraoka K, Yamamoto A, Uchida T, Iwata S, Yamaguchi Y, Krayukhina E, Noda M, Handa H, Ishimori K, Uchiyama S, Kobayashi T, Suematsu M (2016) Haem-dependent dimerization of PGRMC1\/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nature Communications 7:11030. doi:10.1038\/ncomms11030","journal-title":"Nature Communications"},{"key":"2080_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1034\/j.1600-0773.2001.d01-108.x","volume":"88","author":"P Kasper","year":"2001","unstructured":"Kasper P (2001) Cyproterone acetate: a genotoxic carcinogen? Pharmacol Toxicol 88:223\u2013231","journal-title":"Pharmacol Toxicol"},{"key":"2080_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/bioinformatics\/btn647","volume":"25","author":"A Kauffmann","year":"2009","unstructured":"Kauffmann A, Gentleman R, Huber W (2009) ArrayQualityMetrics\u2014a bioconductor package for quality assessment of microarray data. Bioinformatics 25:415\u2013416. doi:10.1093\/bioinformatics\/btn647","journal-title":"Bioinformatics"},{"key":"2080_CR18","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G (2016) Hepatocellular carcinoma. Nat Rev Dis Primers 2:16018. doi:10.1038\/nrdp.2016.18","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2080_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/carcin\/21.1.79","volume":"21","author":"A L\u00f6w-Baselli","year":"2000","unstructured":"L\u00f6w-Baselli A, Hufnagl K, Parzefall W, Schulte-Hermann R, Grasl-Kraupp B (2000) Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis. Carcinogenesis 21(1):79\u201386","journal-title":"Carcinogenesis"},{"key":"2080_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrc1546","volume":"5","author":"A Luch","year":"2005","unstructured":"Luch A (2005) Nature and nurture-lessons from chemical carcinogenesis. Nat Rev Cancer 5:113\u2013125. doi:10.1038\/nrc1546","journal-title":"Nat Rev Cancer"},{"key":"2080_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1586\/17474124.2014.934358","volume":"8","author":"GK Michalopoulos","year":"2014","unstructured":"Michalopoulos GK (2014) Advances in liver regeneration. Expert Rev Gastroenterol Hepatol 8:897\u2013907. doi:10.1586\/17474124.2014.934358","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2080_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1126\/scisignal.2003705","volume":"6","author":"S Mutoh","year":"2013","unstructured":"Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, Negishi M (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6:31. doi:10.1126\/scisignal.2003705","journal-title":"Sci Signal"},{"key":"2080_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/newbio233181a0","volume":"233","author":"SK Park","year":"1971","unstructured":"Park SK, Brody JI (1971) Suppression of immunity by phenobarbital. Nat New Biol 233:181\u2013182","journal-title":"Nat New Biol"},{"key":"2080_CR24","first-page":"1143","volume":"51","author":"W Parzefall","year":"1991","unstructured":"Parzefall W, Erber E, Sedivy R, Schulte-Hermann R (1991) Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res 51:1143\u20131147","journal-title":"Cancer Res"},{"key":"2080_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/carcin\/22.3.519","volume":"22","author":"W Parzefall","year":"2001","unstructured":"Parzefall W, Berger W, Kainzbauer E, Teufelhofer O, Schulte-Hermann R, Thurman RG (2001) Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis 22:519\u2013523","journal-title":"Carcinogenesis"},{"key":"2080_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s15010-007-7240-3","volume":"36","author":"A Ploppa","year":"2008","unstructured":"Ploppa A, Kiefer RT, Noh\u00e9 B, Haeberle HA, Dieterich HJ, Unertl KE, Durieux ME, Krueger WA (2008) Monocyte phagocytosis of viable Staphylococcus aureus is impaired by barbiturates, but not by propofol. Infection 36:220\u2013225. doi:10.1007\/s15010-007-7240-3","journal-title":"Infection"},{"key":"2080_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4419-9967-2_11","volume":"754","author":"IP Pogribny","year":"2013","unstructured":"Pogribny IP, Rusyn I (2013) Environmental toxicants, epigenetics, and cancer. Adv Exp Med Biol 754:215\u2013232. doi:10.1007\/978-1-4419-9967-2_11","journal-title":"Adv Exp Med Biol"},{"key":"2080_CR28","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/carcin\/bgv135","volume":"36","author":"T Riegler","year":"2015","unstructured":"Riegler T, Nejabat M, Eichner J, Stiebellehner M, Subosits S, Bilban M, Zell A, Huber WW, Schulte-Hermann R, Grasl-Kraupp B (2015) Proinflammatory mesenchymal effects of the non-genotoxic hepatocarcinogen phenobarbital: a novel mechanism of antiapoptosis and tumor promotion. Carcinogenesis 36:1521\u20131530. doi:10.1093\/carcin\/bgv135","journal-title":"Carcinogenesis"},{"key":"2080_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/toxsci\/kfl173","volume":"96","author":"RA Roberts","year":"2007","unstructured":"Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE (2007) Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96:2\u201315. doi:10.1093\/toxsci\/kfl173","journal-title":"Toxicol Sci"},{"key":"2080_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/08923979209005403","volume":"14","author":"F Rossano","year":"1992","unstructured":"Rossano F, Tufano R, Cipollaro de L\u2019Ero G, Servillo G, Baroni A, Tufano MA (1992) Anesthetic agents induce human mononuclear leucocytes to release cytokines. Immunopharmacol Immunotoxicol 14:439\u2013450. doi:10.3109\/08923979209005403","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2080_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1124\/mol.54.6.1113","volume":"54","author":"EG Schuetz","year":"1998","unstructured":"Schuetz EG, Brimer C, Schuetz J (1998) Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharmacol 54:1113\u20131117","journal-title":"Mol Pharmacol"},{"key":"2080_CR32","first-page":"2556","volume":"41","author":"R Schulte-Hermann","year":"1981","unstructured":"Schulte-Hermann R, Ohde G, Schuppler J, Timmermann-Trosiener I (1981) Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res 41:2556\u20132562","journal-title":"Cancer Res"},{"key":"2080_CR33","first-page":"5127","volume":"50","author":"R Schulte-Hermann","year":"1990","unstructured":"Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W (1990) DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50:5127\u20135135","journal-title":"Cancer Res"},{"key":"2080_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-642-67265-1_16","volume":"2","author":"J Schuppler","year":"1979","unstructured":"Schuppler J, G\u00fcnzel P (1979) Liver tumours and steroid hormones in rats and mice. Arch Toxicol 2:181\u2013195","journal-title":"Arch Toxicol"},{"key":"2080_CR35","first-page":"270","volume":"74","author":"PA Shapiro","year":"1980","unstructured":"Shapiro PA, Antonioli DA, Peppercorn MA (1980) Barbiturate-induced submassive hepatic necrosis. Report of a case and review of the literature. Am J Gastroenterol 74:270\u2013273","journal-title":"Am J Gastroenterol"},{"key":"2080_CR36","doi-asserted-by":"publisher","first-page":"e61802","DOI":"10.1371\/journal.pone.0061802","volume":"8","author":"R Shizu","year":"2013","unstructured":"Shizu R, Benoki S, Numakura Y, Kodama S, Miyata M, Yamazoe Y, Yoshinari K (2013) Xenobiotic-induced hepatocyte proliferation associated with constitutive active\/androstane receptor (CAR) or peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) is enhanced by pregnane X receptor (PXR) activation in mice. PLoS ONE 8:e61802. doi:10.1371\/journal.pone.0061802","journal-title":"PLoS ONE"},{"key":"2080_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:1\u201325","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2080_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.steroids.2016.02.015","volume":"111","author":"T Tokumoto","year":"2016","unstructured":"Tokumoto T, Hossain MB, Wang J (2016) Establishment of procedures for studying mPR-interacting agents and physiological roles of mPR. Steroids 111:79\u201383. doi:10.1016\/j.steroids","journal-title":"Steroids"},{"key":"2080_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","volume":"44","author":"E Trinka","year":"2017","unstructured":"Trinka E, K\u00e4lvi\u00e4inen R (2017) 25\u00a0years of advances in the definition, classification and treatment of status epilepticus. Seizure 44:65\u201373. doi:10.1016\/j.seizure.2016.11.001","journal-title":"Seizure"},{"key":"2080_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/labinvest.2015.36","volume":"95","author":"N Urakawa","year":"2015","unstructured":"Urakawa N, Utsunomiya S, Nishio M, Shigeoka M, Takase N, Arai N, Kakeji Y, Koma Y, Yokozaki H (2015) GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways. Lab Invest 95:491\u2013503. doi:10.1038\/labinvest.2015.36","journal-title":"Lab Invest"},{"key":"2080_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2188\/jea.7.173","volume":"7","author":"S Watanabe","year":"1997","unstructured":"Watanabe S, Cui Y, Tanae A, Tanaka T, Fujimoto M, Matsuo Y, Tachibana K, Yamasaki S (1997) Follow-up study of children with precocious puberty treated with cyproterone acetate. Ad hoc Committee for CPA. J Epidemiol 7:173\u2013178","journal-title":"J Epidemiol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-2080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-017-2080-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-017-2080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T22:14:18Z","timestamp":1630620858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-017-2080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1007\/s00204-017-2080-0","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2017,12,21]]},"assertion":[{"value":"11 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}